Costs remain competitive at Sheridan Memorial Hospital

Sheridan Memorial Hospital not only provides a high level of quality and a high level of service, but a high level of value to the hospital’s patients.

That’s according to the hospital’s CEO Mike McCafferty in a report to hospital trustees during their meeting Wednesday night.

McCafferty said Sheridan Memorial ranks second in the state and third in the region for costs of procedures like colonoscopy and biopsy.

That includes Medicare spending per beneficiary, he said.

He said Sheridan Memorial Hospital has set costs to be very competitive to the rest of the state and to the country.

Turning to other matters in their meeting Wednesday, hospital trustees accepted the audit report for fiscal year 2020 and approved a resolution relating to the Wilson Memorial Trust.

Hospital CEO Nathan Stutte said the resolution pertained to a change in how trusts distribute money to organizations. He said a trust now has to distribute funds into a bank account that’s in the name of the recipient organization.

He said that means the hospital no longer has to go to the Wilson Memorial Trust to ask their permission to use those funds. He said what the resolution does is state that the hospital will honor the intent of the memorial trust in using the funds for capital improvements.